Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

1. Pooling analysis reveals that galectin-1 is a reliable prognostic biomarker in various cancers.Journal of cellular physiology · 2019
   Pooled it
2. Healing mechanisms of Galectin-1 in the ischemic heart.Cell biochemistry and biophysics · 2026
   Review
3. SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A/BNIP3/mitophagy axis.Journal of translational medicine · 2025
   Article
4. Exploring the Potential Causal Relationship of Galectin Levels and Gynecologic Cancers: A Two-Sample Mendelian Randomization Study.International journal of women's health · 2025
   Article
5. Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma.Biomedicines · 2024
   Article
6. LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway.Gland surgery · 2022
   Article
7. The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review).Molecular medicine reports · 2022
   Article
8. ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma.NPJ precision oncology · 2022
   Article
9. Overexpression of galectin2 (LGALS2) predicts a better prognosis in human breast cancer.American journal of translational research · 2022
   Article
10. Galectin-1-Dependent Mitochondria Apoptosis Plays an Essential Role in the Potential Protein Targets of DBDCT-Induced Hepatotoxicity as Revealed by Quantitative Proteomic Analyses.Bioinorganic chemistry and applications · 2022
    Article
11. lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress.Molecular therapy. Nucleic acids · 2021
    Article
12. High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer.Cancer cell international · 2020
    Article
13. The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.Frontiers in cell and developmental biology · 2020
    Review
14. Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.Journal of experimental & clinical cancer research : CR · 2019
    Article
15. Mitochondrial Involvement in Cisplatin Resistance.International journal of molecular sciences · 2019
    Review
16. Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis.Cancer cell international · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as